With CMS introducing new guidance for RWD studies, the FDA announcing a new RWE Center, and RWD becoming more accessible, it is clear that RWE will play an increasingly pivotal role in the drug development lifecycle. But uncertainties still remain for the experts applying RWE.
Returning to Boston, the 13th IMPACCT Real-World Evidence Summit is the only industry-focused meeting dedicated to uniting RWE experts to consolidate and optimize their RWE strategies. Join 140+ industry pioneers from top pharma and biotech companies, as they share real-world case studies, the latest industry insights, and transformative strategies to upskill your team with the knowledge to advance your RWE utility.
What Can You Expect?
- Hear how Pfizer are using AI to refine data quality through optimized data generation, data pipeline automation, and data augmentation.
- Identify key tokenization methods to ensure consistency, interoperability, and improved data utility for regulatory and payer decision making with AstraZeneca.
- Learn how Abbvie are empowering their value and evidence teams with timely insights to support market access and strategic planning.
- Build a centralized evidence strategy that aligns your cross-functional teams and ensures consistent objectives with Otsuka and Ionis Pharmaceuticals.
Discover the extensive list of sessions, speakers and case studies in our agenda!
Seize your opportunity to gain invaluable industry insights, address challenges and foster connections, to perfect your data-quality and enhance your RWE approaches.